Compositions for modulating expression of C9ORF72 antisense transcript
US10407678B2 · kind B2 · utility
3Cited by
187References
35Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 16, 2015 |
| Grant date | Sep 10, 2019 |
| Priority date | — |
| Expiry date | Apr 16, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/341
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions and methods for modulating expression of C9ORF72 antisense transcript in a cell or animal with C9ORF72 antisense transcript specific inhibitors. Such methods are useful to treat, prevent, or ameliorate neurodegenerative diseases in an individual in need thereof. Such C9ORF72 antisense transcript specific inhibitors include antisense compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.